Editorial and compliance policy

How content is made

Drafts are produced with AI assistance from a structured brief and a primary-source requirement: PubMed-indexed studies, FDA documents, and state licensing boards. Every page carries the date it was last verified.

Compliance gate

Before anything publishes, it passes an automated review against the language FDA cited in its 2026 warning letters to GLP-1 telehealth marketers and peptide sellers, plus FTC endorsement rules. Content that calls a compounded drug "FDA-approved," implies equivalence to a brand drug, gives dosing, or omits risk information is blocked.

Clinical review

We are recruiting a licensed naturopathic doctor as clinical reviewer. Until that role is filled, pages are labeled AI-assisted and source-cited rather than clinician-reviewed. We will not claim a review that did not happen.

Corrections

Email corrections@peptidebotanica.com. We fix errors within 48 hours and note the change on the page.

Ask a questionAnswers with sources. No dosing.

Ask how GLP-1 or peptide therapy works, what it costs, or what a holistic protocol around it looks like.

Find a provider in my state